Smith & Nephew stock slips as FTSE 100 gains on Bank of England decision
Published on 09/17/2026 at 21:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Smith & Nephew stock (ISIN GB0009223206) traded softer in London on September 17, 2026, with the medical technology group among the decliners in an otherwise rising FTSE 100 environment after the Bank of England left interest rates unchanged.
Smith & Nephew lags a strong FTSE 100 session
According to finanzen.ch on September 17, 2026, Smith & Nephew shares fell 1.10 percent to 10.31 GBP on the London Stock Exchange, while the FTSE 100 index itself showed a clearly positive day.
As finanzen.ch reports, the FTSE 100 rose about 0.5 percent after the Bank of England decided to keep its key interest rate unchanged on September 17, 2026, underscoring that Smith & Nephew underperformed the broader index on the day.
Valuation context and sector positioning
Beyond the daily move, the valuation backdrop remains an important context for Smith & Nephew stock. In a top-picks discussion published on September 17, 2026, BNN Bloomberg highlighted Smith & Nephew, noting that the stock trades on roughly 11 to 12 times expected earnings over the next 12 months, a clear discount to market leader Stryker.
This discount multiple is one of the reasons some portfolio managers still view the shares as attractive within the orthopedic and wound-care segment, even though the whole medical devices industry has been derated in recent years, according to the same BNN Bloomberg feature.
Stock level and investor takeaway
Per the London snapshot cited by finanzen.ch, Smith & Nephew stock changing hands at 10.31 GBP in London on September 17, 2026, reflects a modest decline on the day but keeps the shares within a valuation band that some investors see as offering potential relative to sector peers.
Smith & Nephew stock facts
- Company: Smith & Nephew plc
- ISIN: GB0009223206
- Ticker: SN
- Trading venue: London Stock Exchange
- Price (as of September 17, 2026): 10.31 GBP
- Sector / Industry: Health Care / Medical Devices
- Index membership: FTSE 100
